Axsome Therapeutics, Inc.
AXSM
Kedudukan dalam Saham
#2361
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Harga Saham
$159.65
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$8.36B
Perubahan (1 hari)
2.46%
Perubahan (1 tahun)
21.51%
Negara
US
Perdagangan Axsome Therapeutics, Inc. (AXSM)
Kategori
Healthcare
Sejarah pecahan saham untuk Axsome Therapeutics, Inc. (AXSM)
Saham Axsome Therapeutics, Inc. (simbol: AXSM) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham AXSM yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham AXSM.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham AXSM yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham AXSM.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|